|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-5-21
|
|
pubmed:abstractText |
A definitive combined modality therapy superior to surgery alone has not yet been found for esophageal cancer. This retrospective study investigated the impact of postoperative adjuvant chemotherapy in patients who underwent curative (R0) esophagectomy with radical lymphadenectomy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0253-4886
|
|
pubmed:author |
pubmed-author:FujitaHiromasaH,
pubmed-author:HeroorAnilA,
pubmed-author:MatonoSatoruS,
pubmed-author:MineTakashiT,
pubmed-author:ORRR BRB,
pubmed-author:SasaharaHirokoH,
pubmed-author:ShirouzuKazuoK,
pubmed-author:SudoTomoyaT,
pubmed-author:SueyoshiSusumuS,
pubmed-author:TanakaToshiakiT,
pubmed-author:YamanaHideakiH
|
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
229-35; discussion 236-7
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12759503-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12759503-Carcinoma, Squamous Cell,
pubmed-meshheading:12759503-Chemotherapy, Adjuvant,
pubmed-meshheading:12759503-Cisplatin,
pubmed-meshheading:12759503-Combined Modality Therapy,
pubmed-meshheading:12759503-Drug Administration Schedule,
pubmed-meshheading:12759503-Esophageal Neoplasms,
pubmed-meshheading:12759503-Esophagectomy,
pubmed-meshheading:12759503-Female,
pubmed-meshheading:12759503-Fluorouracil,
pubmed-meshheading:12759503-Humans,
pubmed-meshheading:12759503-Lymph Node Excision,
pubmed-meshheading:12759503-Male,
pubmed-meshheading:12759503-Middle Aged,
pubmed-meshheading:12759503-Prognosis,
pubmed-meshheading:12759503-Retrospective Studies,
pubmed-meshheading:12759503-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective study.
|
|
pubmed:affiliation |
Department of Surgery, Kurume University School of Medicine, Fukuoka, Japan.
|
|
pubmed:publicationType |
Journal Article
|
